Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$132.88
+0.4%
$132.19
$99.71
$141.23
$231.20B0.736.10 million shs11.32 million shs
Belgravia Capital International Inc stock logo
BLGV
Belgravia Capital International
$0.00
$0.00
$0.00
N/AN/AN/A12.39 million shs
Phoenix Tree Holdings Limited Sponsored ADR stock logo
DNK
Phoenix Tree
$2.37
$2.34
$1.27
$13.35
N/AN/AN/AN/A
7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025 Cover

Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Abbott Laboratories stock logo
ABT
Abbott Laboratories
0.00%-1.87%+1.20%+4.38%+25.69%
Belgravia Capital International Inc stock logo
BLGV
Belgravia Capital International
0.00%0.00%0.00%0.00%0.00%
Phoenix Tree Holdings Limited Sponsored ADR stock logo
DNK
Phoenix Tree
0.00%0.00%0.00%0.00%0.00%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Abbott Laboratories stock logo
ABT
Abbott Laboratories
4.9311 of 5 stars
2.45.04.24.53.02.52.5
Belgravia Capital International Inc stock logo
BLGV
Belgravia Capital International
N/AN/AN/AN/AN/AN/AN/AN/A
Phoenix Tree Holdings Limited Sponsored ADR stock logo
DNK
Phoenix Tree
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Abbott Laboratories stock logo
ABT
Abbott Laboratories
2.76
Moderate Buy$142.617.32% Upside
Belgravia Capital International Inc stock logo
BLGV
Belgravia Capital International
0.00
N/AN/AN/A
Phoenix Tree Holdings Limited Sponsored ADR stock logo
DNK
Phoenix Tree
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest NUF, ABT, BLGV, and DNK Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/16/2025
Abbott Laboratories stock logo
ABT
Abbott Laboratories
Leerink Partnrs
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold
6/16/2025
Abbott Laboratories stock logo
ABT
Abbott Laboratories
Leerink Partners
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageMarket Perform$143.00
4/17/2025
Abbott Laboratories stock logo
ABT
Abbott Laboratories
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$133.00 ➝ $145.00
4/17/2025
Abbott Laboratories stock logo
ABT
Abbott Laboratories
Raymond James Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$132.00 ➝ $142.00
4/17/2025
Abbott Laboratories stock logo
ABT
Abbott Laboratories
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$140.00 ➝ $145.00
4/17/2025
Abbott Laboratories stock logo
ABT
Abbott Laboratories
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetEqual Weight ➝ Equal Weight$117.00 ➝ $127.00
4/17/2025
Abbott Laboratories stock logo
ABT
Abbott Laboratories
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$136.00 ➝ $147.00
4/17/2025
Abbott Laboratories stock logo
ABT
Abbott Laboratories
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$158.00 ➝ $159.00
4/17/2025
Abbott Laboratories stock logo
ABT
Abbott Laboratories
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$135.00 ➝ $145.00
4/17/2025
Abbott Laboratories stock logo
ABT
Abbott Laboratories
Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetHold ➝ Hold$135.00 ➝ $137.00
(Data available from 6/23/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$41.95B5.51$6.58 per share20.20$27.62 per share4.81
Belgravia Capital International Inc stock logo
BLGV
Belgravia Capital International
N/AN/AN/AN/AN/AN/A
Phoenix Tree Holdings Limited Sponsored ADR stock logo
DNK
Phoenix Tree
N/AN/AN/AN/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$13.40B$7.7117.2423.192.5331.89%19.01%10.82%7/17/2025 (Estimated)
Belgravia Capital International Inc stock logo
BLGV
Belgravia Capital International
N/AN/A0.00N/AN/AN/AN/AN/AN/A
Phoenix Tree Holdings Limited Sponsored ADR stock logo
DNK
Phoenix Tree
N/AN/A0.00N/AN/AN/AN/AN/A

Latest NUF, ABT, BLGV, and DNK Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
7/17/2025Q2 2025
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$1.25N/AN/AN/A$11.01 billionN/A
4/16/2025Q1 2025
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$1.07$1.09+$0.02$0.76$10.38 billion$10.36 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$2.361.78%N/A30.61%54 Years
Belgravia Capital International Inc stock logo
BLGV
Belgravia Capital International
N/AN/AN/AN/AN/A
Phoenix Tree Holdings Limited Sponsored ADR stock logo
DNK
Phoenix Tree
N/AN/AN/AN/AN/A

Latest NUF, ABT, BLGV, and DNK Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
6/13/2025
Abbott Laboratories stock logo
ABT
Abbott Laboratories
quarterly$0.591.73%7/15/20257/15/20258/15/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Abbott Laboratories stock logo
ABT
Abbott Laboratories
0.26
1.78
1.27
Belgravia Capital International Inc stock logo
BLGV
Belgravia Capital International
N/AN/AN/A
Phoenix Tree Holdings Limited Sponsored ADR stock logo
DNK
Phoenix Tree
N/AN/AN/A

Institutional Ownership

CompanyInstitutional Ownership
Abbott Laboratories stock logo
ABT
Abbott Laboratories
75.18%
Belgravia Capital International Inc stock logo
BLGV
Belgravia Capital International
N/A
Phoenix Tree Holdings Limited Sponsored ADR stock logo
DNK
Phoenix Tree
N/A

Insider Ownership

CompanyInsider Ownership
Abbott Laboratories stock logo
ABT
Abbott Laboratories
0.46%
Belgravia Capital International Inc stock logo
BLGV
Belgravia Capital International
N/A
Phoenix Tree Holdings Limited Sponsored ADR stock logo
DNK
Phoenix Tree
N/A
CompanyEmployeesShares OutstandingFree FloatOptionable
Abbott Laboratories stock logo
ABT
Abbott Laboratories
114,0001.74 billion1.73 billionOptionable
Belgravia Capital International Inc stock logo
BLGV
Belgravia Capital International
N/AN/AN/ANot Optionable
Phoenix Tree Holdings Limited Sponsored ADR stock logo
DNK
Phoenix Tree
4,506N/AN/ANot Optionable

Recent News About These Companies

Tree-lighting ceremony returns to Phoenix
AZ's tallest Christmas tree arrives in Anthem
Phoenix seeks $50M to add shade over 5 years

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Abbott Laboratories stock logo

Abbott Laboratories NYSE:ABT

$132.88 +0.47 (+0.36%)
Closing price 06/20/2025 03:59 PM Eastern
Extended Trading
$133.12 +0.23 (+0.17%)
As of 06/20/2025 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for laboratories. In addition, the company provides pediatric and adult nutritional products; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.

Belgravia Capital International stock logo

Belgravia Capital International CNSX:BLGV

Belgravia Hartford Capital Inc., an investment holding company, focuses on incubation, investment, and royalty and management service businesses. The company offers merchant banking services; and services to support the development of early-stage companies. It also invests in various private and public companies with a focus on resources, technology, and healthcare sectors. The company was formerly known as Belgravia Capital International Inc. and changed its name to Belgravia Hartford Capital Inc. in December 2019. Belgravia Hartford Capital Inc. is based in Kelowna, Canada.

Phoenix Tree stock logo

Phoenix Tree NYSE:DNK

Phoenix Tree Holdings Limited, through its subsidiaries, leases apartments from property owners and rents them to residents and corporate clients in the People's Republic of China. It designs, renovates, and furnishes apartments; and provides WiFi, 24/7 resident support, and common area maintenance and utilities to the residents, as well as repair and maintenance for private rooms. As of December 31, 2019, it operated 438,309 apartment units; and nine apartment facilities under the Dream Apartment brand name with a total of 8,558 beds and four additional facilities in Beijing, Shanghai, and Shenzhen. The company was founded in 2015 and is headquartered in Beijing, China.